---
category: news
title: "Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus’ Leadership in Prostate Cancer"
excerpt: "Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced today that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S."
publishedDateTime: 2021-07-30T02:25:00Z
originalUrl: "https://www.businesswire.com/news/home/20210729006210/en/Lantheus-Announces-the-First-and-Only-FDA-Cleared-AI-Enabled-PSMA-Digital-Application-aPROMISE™-Strengthening-Lantheus’-Leadership-in-Prostate-Cancer"
webUrl: "https://www.businesswire.com/news/home/20210729006210/en/Lantheus-Announces-the-First-and-Only-FDA-Cleared-AI-Enabled-PSMA-Digital-Application-aPROMISE™-Strengthening-Lantheus’-Leadership-in-Prostate-Cancer"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "eywC47oYaXxUBIuYMCjo3PFXWvYUh+eNyULWLmmfX0YjBsVQbywno6W0QvMrIIV9xhoXQLT+jyg1uLHw0CyzHEhutspGlYzVz3A/wdLzHiBLropKD0v6XnVTxV6M9BlTgzeQazMSw7l/8FHG9dxWMEpG/jBiV6ntD9t/NwVbw9co+WaErCOLY7Ab9Q8NLywhFEl6gBJ4nGAMkEBTzve36nPJWMgzAqK9vAyt2+vqO3EhSMc4Tz49LJ12WTblcDr5R1Luxy+A8n4sGXOa1pB63YPLLZ2T1LdPq5IFCgbI42zevyird0ctADK8mCVGsYGTl/Mc4mD5i9hsqtnIlndM+X7qLhBoL45F15VEH/X0+FA=;jHzFd5vSgvyMwmv4JHdK/g=="
---

